CORONAVIRUS/Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
Taipei, Aug. 20 (CNA) An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Taiwan's weekly COVID-19 infections down 3%, mostly BA.5]()
Taiwan's weekly COVID-19 infections down 3%, mostly BA.5The number of COVID-19 infections in Taiwan dropped last week for the first time in over a month, falling by 3 percent from a week earlier, with cases caused by the BA.5 ...09/26/2022 06:37 PM![Taiwan reports 28,785 new COVID-19 cases, 56 deaths]()
Taiwan reports 28,785 new COVID-19 cases, 56 deathsTaiwan reported 28,785 new COVID-19 infections and 56 deaths from the disease Monday, according to the Central Epidemic Command Center (CECC).09/26/2022 04:04 PM![Next round of rapid test rationing plan to start Oct. 1]()
Next round of rapid test rationing plan to start Oct. 1The sixth round of the government's COVID-19 rapid test rationing scheme will begin on Oct. 1, with every holder of a national health insurance (NHI) card or Alien Residence ...09/26/2022 03:36 PM
Latest
- Politics
Former U.S. top diplomat Mike Pompeo arrives in Taiwan
09/26/2022 10:30 PM - Sports
HeroBears to face DEA in interleague basketball tournament final
09/26/2022 09:55 PM - Science & Tech
Jupiter to make closest approach to Earth in 59 years: Museum
09/26/2022 09:36 PM - Culture
Taipei museum to hold exhibition on Southeast Asian cultural relics
09/26/2022 09:32 PM - Business
Manufacturing business sentiment weakens to over 2-year low
09/26/2022 09:06 PM